结论：东菱克栓酶是治疗糖尿病足有效药物。
Conclusion: Batroxobin is an effective medicine for cure diabetic foot.
探讨东菱迪芙联合丁苯酞对急性期脑梗死治疗效果。
Investigate the effect of the Batroxobin United Butylphthalide on the treatment of acute cerebral infarction.
目的观察东菱克栓酶治疗血液病合并高粘血症的临床疗效。
Objective to observe the effects of batroxobin in the treatment of hematologic diseases complicated with high ropiness (or thrombosis).
东菱精纯克栓酶是一种单成分溶血栓促微循环的新型血栓治疗剂。
Batroxobin is a new thrombolytic drug, which is made up of single composition and can improve the blood microcirculation.
目的观察低分子肝素钙联合东菱克栓酶治疗进展性脑梗死的疗效。
Objective To observe the therapeutic efficacy of combination of low-molecular weight heparin and Batroxobin(DF-521)on progressive stroke.
与顺德东菱电器股份有限公司合作的家用系列研磨产品开发设计；
Grinding Products Research and Design . Cooperated with Shunde Dongling Electric Co. , Ltd.
目的探讨东菱克栓酶治疗急性脑梗死对凝血与纤溶系统的影响及意义。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in patients with acute cerebral infarction.
目的观察并了解东菱精纯克栓酶对荷瘤裸鼠全血流变学参数值的影响。
Objective To observe the effects of Batroxobin on the hemorheology in the whole blood of Nude mice with gastric and nasopharynegal carcinoma.
目的探讨急性脑梗塞患者用东菱克栓酶治疗对其凝血与纤溶系统的影响。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in the patients with acute cerebral infarction.
目的观察东菱精纯克栓酶(DF- 521)治疗爆震性耳聋的临床疗效。
Objective To observe the clinical effect of batroxobin (DF-521) in the treatment of explosion hearing loss.
目的探讨急性脑卒中后及东菱迪芙治疗急性脑梗塞血浆MMP-9变化的临床意义。
Objective To investigate the changes of MMP-9 in acute stroke patients and the clinical significance of MMP-9 in patients with acute cerebral infarction treated with Batroxobin injection (DF-521).
目的：观察东菱精纯克栓酶（DF- 5 2 1）对豚鼠爆震性听损伤的影响。
Objective: To observe the protective effect of batroxobin(DF-521) on blast-induced hearing loss in guinea pigs.
治疗组在同对照组治疗的基础上，于第1、3、5天分别给予东菱克栓酶10BU、5BU、5BU。
The therapy group, Batroxobin 10BU, 5BU , 5BU were adminiatated at 1,3,5 days after diagnosis.
治疗组在同对照组治疗的基础上，于第1、3、5天分别给予东菱克栓酶10BU、5BU、5BU。
The therapy group, Batroxobin 10BU, 5BU , 5BU were adminiatated at 1,3,5 days after diagnosis.
应用推荐